Fideuram Asset Management Ireland dac Makes New $460,000 Investment in Corteva, Inc. $CTVA

Fideuram Asset Management Ireland dac bought a new position in shares of Corteva, Inc. (NYSE:CTVAFree Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 7,365 shares of the company’s stock, valued at approximately $460,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Vanguard Group Inc. raised its position in Corteva by 0.4% during the fourth quarter. Vanguard Group Inc. now owns 80,536,951 shares of the company’s stock worth $5,398,392,000 after acquiring an additional 317,538 shares during the last quarter. State Street Corp grew its holdings in shares of Corteva by 3.6% during the third quarter. State Street Corp now owns 35,280,805 shares of the company’s stock worth $2,386,041,000 after buying an additional 1,230,074 shares in the last quarter. Franklin Resources Inc. grew its holdings in shares of Corteva by 5.9% during the third quarter. Franklin Resources Inc. now owns 18,731,627 shares of the company’s stock worth $1,266,820,000 after buying an additional 1,051,389 shares in the last quarter. Northern Trust Corp grew its holdings in shares of Corteva by 1.8% during the third quarter. Northern Trust Corp now owns 11,169,284 shares of the company’s stock worth $755,379,000 after buying an additional 194,728 shares in the last quarter. Finally, Legal & General Group Plc grew its holdings in shares of Corteva by 14.3% during the third quarter. Legal & General Group Plc now owns 5,753,982 shares of the company’s stock worth $389,142,000 after buying an additional 720,469 shares in the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on CTVA. Jefferies Financial Group lifted their price target on shares of Corteva from $95.00 to $97.00 in a report on Thursday, May 7th. Rothschild & Co Redburn lifted their price target on shares of Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a report on Wednesday, April 29th. The Goldman Sachs Group lifted their price target on shares of Corteva from $88.00 to $96.00 and gave the stock a “buy” rating in a report on Tuesday, April 14th. Wolfe Research lifted their price target on shares of Corteva from $81.00 to $86.00 and gave the stock an “outperform” rating in a report on Thursday, February 5th. Finally, Citigroup lifted their price target on shares of Corteva from $83.00 to $85.00 and gave the stock a “neutral” rating in a report on Thursday, May 7th. Fourteen research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat, Corteva has an average rating of “Moderate Buy” and an average target price of $88.67.

View Our Latest Stock Report on Corteva

Corteva Price Performance

Corteva stock opened at $78.41 on Friday. Corteva, Inc. has a 1 year low of $60.53 and a 1 year high of $85.63. The firm has a 50 day moving average price of $81.33 and a 200 day moving average price of $74.53. The company has a market cap of $52.44 billion, a price-to-earnings ratio of 46.12, a PEG ratio of 2.39 and a beta of 0.59. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47.

Corteva (NYSE:CTVAGet Free Report) last released its earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The firm had revenue of $4.91 billion during the quarter, compared to the consensus estimate of $4.64 billion. During the same period in the previous year, the firm earned $1.13 earnings per share. Corteva’s revenue was up 11.0% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Sell-side analysts predict that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Investors of record on Monday, June 1st will be issued a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Monday, June 1st. Corteva’s payout ratio is presently 42.35%.

Corteva Profile

(Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Featured Articles

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVAFree Report).

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.